We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Breaking the 1 Angstrom Imaging Barrier

By Biotechdaily staff writers
Posted on 08 Apr 2004
A new 200 kv transmission electron microscope (TEM) allows images for the first time to be directly viewed with a resolution of less than one angstrom, using commercially available technologies.

One angstrom is one-tenth of a nanometer in size, and a nanometer is one billionth of a meter. More...
One angstrom is also about one-third the size of a carbon atom and is a key dimension for atomic-level research. Now, scientists at FEI Company (Hillsboro, OR, USA) have broken the 1 angstrom high resolution imaging barrier with this new microscope.

The ability to attain direct artifact-free images of atoms opens the doors for researchers working in nanotechnology development to explore materials at the highest resolution ever. The sub-Angstrom resolution was achieved by using FEI's Tecnai F20 transmission electron microscope employing technologies that improve image resolution with advanced electron optics capabilities developed by FEI and its partner, CEOS Company (Corrected Electron Optical Systems, Heidelberg, Germany). This permits novel TEM techniques, such as 3D reconstruction with tomography, scanning probe applications, or in situ observation of specimen responses to variations in temperature, stress, or chemical environment--all with sub-Angstrom resolutions.

"The successful use of an electron beam monochromator to improve the resolution of a Cs-corrected electron microscope marks a major milestone for the field of electron microscopy,” said Dr. Michael O'Keefe of the U.S. National Center of Electron Microscopy (Berkeley, CA, USA). "Theory has long predicted that a monochromator would be able to push the resolution of the super-twin lens beyond the 1.4A resolution demonstrated with the Cs-correction alone.”

FEI Company provides advanced tools for a range of nanotechnology markets, including materials science, life science, semiconductors, and data storage. Its products enable researchers and manufacturers to fabricate and modify nanoscale structures and to view and characterize them in three dimensions down to the atomic level.




Related Links:
FEI Company

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.